Mehmet A. Erkurt

Malatya, 44280, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey.

Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey.

Journal: Journal of clinical medicine

Published: February 01, 2026

Safety Profile of Roxadustat in Anemic Patients: A Meta-Analysis of 21 RCTs.

Safety Profile of Roxadustat in Anemic Patients: A Meta-Analysis of 21 RCTs.

Journal: Medeniyet medical journal

Published: January 02, 2026

Right Ventricular Functional Changes in Patients Undergoing Bone Marrow Transplantation: An Advanced Echocardiographic Analysis.

Right Ventricular Functional Changes in Patients Undergoing Bone Marrow Transplantation: An Advanced Echocardiographic Analysis.

Journal: Echocardiography (Mount Kisco, N.Y.)

Published: December 27, 2025

The HALP score is a novel prognostic biomarker in multiple myeloma: A retrospective cohort study of 450 patients.

The HALP score is a novel prognostic biomarker in multiple myeloma: A retrospective cohort study of 450 patients.

Journal: Medicine

Published: November 08, 2025

Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study.

Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study.

Journal: Journal of clinical medicine

Published: October 26, 2025

Is there a relationship between stem cell yield obtained from healthy donors and healthy donors' blood type?

Is there a relationship between stem cell yield obtained from healthy donors and healthy donors' blood type?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: July 08, 2025

A comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma.

A comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: July 08, 2025

Does body mass index affect stem cell yield in healthy donors?

Does body mass index affect stem cell yield in healthy donors?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: July 03, 2025

Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference to transplant outcomes?

Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference to transplant outcomes?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: June 26, 2025

The role of heparin in autologous stem cell mobilization in patients with multiple myeloma.

The role of heparin in autologous stem cell mobilization in patients with multiple myeloma.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: June 26, 2025

The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes.

The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: June 24, 2025

The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation.

The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: June 21, 2025

Showing 1-12 of 95

Last Updated: 09/26/2026